Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 1/20 | 0.73 |
| ▸ | TTR | P02766 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | METAP2 | P50579 | 1/20 | 0.46 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
| ▸ | HNF4A | P41235 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31596348 | 0.87 | MYC (0.55) | MYCTTRALDH1A1TSHRPOLB | |
| SCHEMBL9512847 | 0.85 | MYC (1.00) | MYCALDH1A1KDM4EUSP2TSHR | |
| SCHEMBL27418584 | 0.84 | MYC (0.53) | MYCTTRALDH1A1POLBGAA | |
| SCHEMBL29848458 | 0.84 | MYC (0.53) | MYCTTRALDH1A1POLBGAA | |
| SCHEMBL28522305 | 0.84 | MYC (0.56) | MYCTTRALDH1A1KDM4EUSP2 | |
| SCHEMBL28506849 | 0.84 | MYC (0.51) | MYCTTRALDH1A1POLBALOX15 | |
| SCHEMBL27645793 | 0.83 | MYC (0.65) | MYCTTRALDH1A1KDM4EUSP2 | |
| SCHEMBL6702122 | 0.81 | MYC (0.58) | MYCALDH1A1KDM4EUSP2TSHR | |
| SCHEMBL28405226 | 0.81 | MYC (0.49) | MYCTTRALDH1A1POLBMETAP2 | |
| SCHEMBL5735556 | 0.81 | MYC (0.49) | MYCTTRALDH1A1POLBMETAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005704-A | Synthesis method of heterocyclic carbon glycoside compound with single configuration | 河南大学 | 2024-05-10 | — | — | CN | claimed |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2022-05-10 | — | — | US | disclosed |
| CN-111825733-A | Macrolides and methods of making and using the same | 哈佛大学的校长及成员们 | 2020-10-27 | — | — | CN | disclosed |
| CN-107430127-B | Cancer markers and methods of use thereof | 中央研究院 | 2020-08-28 | — | — | CN | disclosed |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2017-11-02 | — | — | US | disclosed |
| EP-1681924-A1 | BIPHENYL DERIVATIVE OR ITS SALT, AND PESTICIDE CONTAINING IT AS AN ACTIVE INGREDIENT | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2006-07-26 | — | — | EP | disclosed |
| WO-2005044007-A1 | BIPHENYL DERIVATIVE OR ITS SALT, AND PESTICIDE CONTAINING IT AS AN ACTIVE INGREDIENT | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2005-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | HDGF, F11, F12 | MYC 3726/4885TTR 1749/4885ALDH1A1 1582/4885 |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | HDGF, F11, F12 | MYC 3726/4885TTR 1749/4885ALDH1A1 1582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.